Steven Cohen's SGMT Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 35,629 shares of Sagimet Biosciences Inc. (SGMT) worth $352,015, representing 0.00% of the portfolio. First purchased in 2024-Q1, this medium-term investment has been held for 10 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in SGMT, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2025, adding 175,830 shares. Largest reduction occurred in Q2 2025, reducing 1.76 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Sagimet Biosciences (SGMT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Sagimet Biosciences (SGMT) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2026 | +35,629 | New Buy | 35,629 | $9.88 |
| Q2 2026 | -187,564 | Sold Out | 0 | $0.00 |
| Q1 2026 | +11,734 | Add 6.67% | 187,564 | $5.23 |
| Q4 2025 | +175,830 | New Buy | 175,830 | $5.92 |
| Q2 2025 | -1.76 M | Sold Out | 0 | $0.00 |
| Q1 2025 | -561,429 | Reduce 24.24% | 1.76 M | $3.26 |
| Q4 2024 | -77,356 | Reduce 3.23% | 2.32 M | $4.50 |
| Q3 2024 | +27,838 | Add 1.18% | 2.39 M | $2.77 |
| Q2 2024 | -300,694 | Reduce 11.28% | 2.37 M | $3.42 |
| Q1 2024 | +2.67 M | New Buy | 2.67 M | $5.42 |
Steven Cohen's Sagimet Biosciences Investment FAQs
Steven Cohen first purchased Sagimet Biosciences Inc. (SGMT) in Q1 2024, acquiring 2,666,784 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Sagimet Biosciences Inc. (SGMT) for 10 quarters since Q1 2024.
Steven Cohen's largest addition to Sagimet Biosciences Inc. (SGMT) was in Q1 2024, adding 2,666,784 shares worth $14.45 M.
According to the latest 13F filing for Q3 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 35,629 shares of Sagimet Biosciences Inc. (SGMT), valued at approximately $352,015.
As of the Q3 2026 filing, Sagimet Biosciences Inc. (SGMT) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Sagimet Biosciences Inc. (SGMT) was 2,666,784 shares, as reported at the end of Q1 2024.